dexamethasone,lenalidomide,bortezomib
takeda
['determination']
diversity in clinical trials has continued to be a huge struggle. happy to see nearly 20% aa enrollment in the determination study! an excellent move towards more inclusive clinical trials within mm #asco2022 
@BrandeisU '16, @UICPharm '21, Interests: Oncology/Hematology #TwitteRx #myeloma #WomenInPharmacy | Views my own